Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity

OBJECTIVE: This study aimed to evaluate the preference for antivascular endothelial growth factor (anti-VEGF) versus laser ablation therapy as primary and additional treatment in aggressive retinopathy of prematurity (ROP) and type 1 ROP. METHODS: This multicentre retrospective study was conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Ji Hye, Kang, Yong Koo, Park, Han Sang, Kim, Kiyoung, Kim, Sung Soo, Han, Jae Yong, Kim, Hyun Wong, Bang, Jong Wook, Song, Jae Shin, Park, Sang Jun, Woo, Se Joon, Joo, Kwang Sic, Yoo, Woong-Sun, Chung, Inyoung, Cho, Yong-Wun, Lee, Jong Hyun, Choi, Hun Jin, Chung, Yoo-Ri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Paediatric Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884904/
https://www.ncbi.nlm.nih.gov/pubmed/37278416
http://dx.doi.org/10.1136/bmjophth-2022-001166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884904/
https://www.ncbi.nlm.nih.gov/pubmed/37278416
http://dx.doi.org/10.1136/bmjophth-2022-001166

Ejemplares similares